Uppsala, Sweden – August 11, 2026 – Navinci is pleased to announce the recipients of the 2026 Spatial Interactomics Grant, an initiative supporting innovative research that advances our understanding of biology through the study of protein interactions in their native spatial context.
This year's grant recipients are:
Each recipient will receive our new custom Omni kit, providing access to Navinci's newly launched multiplex spatial interactomics technology and enabling new approaches to studying protein interactions within their native tissue context.
Selected through a competitive review process, the 2026 grant recipients represent leading institutions at the forefront of biomedical research. Their projects demonstrate the growing demand for technologies that can reveal how cells communicate and interact within complex biological systems. Navinci would like to thank all applicants for their interest in this year's program. The high quality and diversity of submissions made the selection process particularly competitive and highlighted the growing interest in spatial interactomics across the research community.
The Spatial Interactomics Grant reflects Navinci's commitment to advancing spatial biology and supporting researchers who are driving new discoveries in areas such as cancer, immunology, and translational medicine.
Navinci congratulates the 2026 grant recipients and looks forward to sharing updates on their research over the coming year.
For further information, please contact:
Sara Twist, Commercial Manager
E-mail: sara.twist@navinci.se
About Navinci
Navinci is a Swedish biotech company specializing in developing innovative solutions for studying in situ protein expression and interactions. With a focus and a strong legacy in developing in situ proximity ligation assay technology, Navinci has established itself as a center of excellence in the field and has a broad portfolio of products that help researchers study protein interactions in depth.